Advert - Jazz Pharmaceutical's UK - Case AUTH/3917/6/24

• Date posted
  11 July 2025
• Sanction
  Advertisement,
• Case number/s
  AUTH/3917/6/24 - Complainant v Jazz Pharmaceuticals

For the failure to include important information relating to the concomitant use of Epidyolex (cannabidiol) and valproate within two online, educational and promotional presentations, Jazz Pharmaceuticals UK was ruled in breach of the following clauses of the 2021 Code:

Clause 2  - Bringing discredit upon, and reducing confidence in, the
pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 6.1 - Making a misleading claim